ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1398

Comparison Of Atherogenicity Of Plasma From Patients With Rheumatoid Arthritis and Psoriatic Arthritis

Beenish Hafiz1, Iryna Voloshyna2, Michael J. Littlefield2, Steven E. Carsons3, Elise Belilos1, Kristina Belostocki1, Lois A. Bonetti4, Gary C. Rosenblum1 and Allison B. Reiss2, 1Rheumatology, Winthrop University Hospital, Mineola, NY, 2Medicine, Winthrop University Hospital, Mineola, NY, 3Div of Rheumatology, Winthrop University Hospital, Mineola, NY, 4Rheum & Immun, Winthrop University Hospital, Mineola, NY

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Cholesterol, Gene Expression, psoriatic arthritis and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Human Etiology and Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Rheumatoid arthritis (RA) and psoriatic arthritis (PsA) are immune mediated inflammatory disorders linked to increased risk of cardiovascular disease (CVD), mostly due to accelerated atherosclerosis. An imbalance between cholesterol inflow and outflow leads to lipid overload and is one mechanism for initiation of atherosclerosis. This study examines the effect of RA and PsA plasma compared to healthy control (HC) plasma on expression of genes responsible for cellular cholesterol efflux and influx by exposing naïve THP-1 human macrophages to RA, PsA and HC plasma. In addition, cytokine levels were measured in RA, PsA and HC.

Methods: THP-1 differentiated macrophages (106 cells/ml, phorbol dibutyrate, 100nM, 48h), were incubated  (370C, 5% C02, 18h) in RPMI 1640 media in the presence of 10% plasma from the following subjects: 1) 22 RA, 2) 21 HC age and sex-matched to the RA group, 3) 8 PsA, 4) 8 HC age matched to the PsA group.  The study was performed under a Winthrop University Hospital IRB-approved protocol. Cytokine levels were evaluated by ELISA. Cholesterol transport protein mRNA was quantified by real-time RT-PCR using specific primers for each gene.

Results: 10% RA plasma increased macrophage expression of cholesterol influx genes (scavenger receptors CD36 and LOX-1). CD36 mRNA increased by 134.45±38.56% (P<0.001) and LOX-1 by 68.9±12.45% (P<0.001) above cells exposed to HC plasma (set at 100%). SR-A1 expression did not different in RA vs. HC. Expression of cholesterol efflux genes (ATP binding cassette transporter (ABC)A1, ABCG1 and 27-hydroxylase) was suppressed in macrophages treated with RA plasma vs. HC plasma. Mean ABCA1 mRNA expression decreased to 55.29±10.23% (P<0.001) compared to cells treated with HC plasma. ABCG1 mRNA fell to 73.65±9.67% (P<0.05) upon exposure to RA plasma vs. HC plasma. 27-Hydroxylase mRNA in THP-1 macrophages in the presence of RA plasma was diminished to 26.5±8.56% (P<0.01). In contrast, 10 % PsA plasma did not alter message level of the cholesterol influx or efflux proteins compared to HC (Figure). Pro-inflammatory cytokines were significantly higher in RA plasma compared to HC plasma: IL-6 (4.66±0.44 pg/ml vs. 1.71±0.045 pg/ml, P<0.01), TNF-α (4.34±0.40 ng/ml vs. 1.30±0.22 ng/ml, P<0.001) and IFN-γ (171.2±125.5 pg/ml vs. 9.54±0.7 pg/ml, P<0.001), respectively. In contrast, PsA plasma did not show significant elevations in IFN-γ, TNF-α or IL-6.

Conclusion: RA plasma but not PsA plasma induced a pro-atherogenic profile of genes responsible for cholesterol infux and efflux. This may be due to the significantly greater elevation of inflammatory cytokines, notably IFN-γ (which is known to alter cellular cholesterol flux in a pro-atherogenic manner) demonstrated in the RA plasma samples. A lack of significant effect on cholesterol transport gene expression by PsA plasma is consistent with less CVD risk in PsA compared to RA.


Disclosure:

B. Hafiz,
None;

I. Voloshyna,
None;

M. J. Littlefield,
None;

S. E. Carsons,
None;

E. Belilos,
None;

K. Belostocki,
None;

L. A. Bonetti,
None;

G. C. Rosenblum,
None;

A. B. Reiss,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/comparison-of-atherogenicity-of-plasma-from-patients-with-rheumatoid-arthritis-and-psoriatic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology